SCHEMBL29544652

SCHEMBL29544652

CNc1cc2c(-c3nn4c(c3Cl)C(=O)NCC4)ccnc2cc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.36
SRC P12931 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
ERBB2 P04626 1/20 0.33
EGFR P00533 2/20 0.32
SYK P43405 1/20 0.32
CCNT1 O60563 4/20 0.32
CDK9 P50750 4/20 0.32
NPC1 O15118 1/20 0.32
KDR P35968 2/20 0.31
LCK P06239 1/20 0.31
MET P08581 1/20 0.31
TEK Q02763 1/20 0.31
TGFBR1 P36897 2/20 0.31
EHMT2 Q96KQ7 1/20 0.31
EHMT1 Q9H9B1 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545041 0.90 PIM1 (0.36) NCF1SRCKDM4EMAPTMAPK1
SCHEMBL29545042 0.90 PIM1 (0.36) NCF1SRCKDM4EMAPTMAPK1
SCHEMBL29544955 0.84 EGFR (0.39) SRCKDM4EEGFRCCNT1CDK9
SCHEMBL29544881 0.84 ATM (0.38) NCF1MAPTEGFRCCNT1CDK9
SCHEMBL29544561 0.81 MET (0.34) NCF1METTGFBR1
SCHEMBL29545167 0.81 PIK3CA (0.32) TGFBR1
SCHEMBL29544572 0.81 EGFR (0.40) EGFRCCNT1CDK9METCSF1R
SCHEMBL29544753 0.75 CCNC (0.36) TGFBR1
SCHEMBL29544635 0.74 NCF1 (0.38) NCF1SRCERBB2EGFRSYK
SCHEMBL29544676 0.74 NCF1 (0.38) NCF1SRCERBB2EGFRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed